The stock of Acal plc (LON:ACL) is a huge mover today! The stock increased 0.95% or GBX 2 on November 30, hitting GBX 213. About 127,164 shares traded hands or 119.57% up from the average. Acal plc (LON:ACL) has declined 19.77% since May 3, 2016 and is downtrending. It has underperformed by 25.00% the S&P500.
The move comes after 9 months positive chart setup for the GBX 135.85 million company. It was reported on Nov, 30 by Barchart.com. We have GBX 227.91 PT which if reached, will make LON:ACL worth GBX 9.51 million more.
Acal plc (LON:ACL) Ratings Coverage
Out of 3 analysts covering Acal PLC (LON:ACL), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Acal PLC has been the topic of 31 analyst reports since July 29, 2015 according to StockzIntelligence Inc. The rating was maintained by Peel Hunt with “Add” on Monday, November 30. The stock of Acal plc (LON:ACL) earned “Buy” rating by FinnCap on Friday, February 12. The firm earned “Add” rating on Friday, January 8 by Peel Hunt. FinnCap maintained the shares of ACL in a report on Friday, January 8 with “Buy” rating. The firm has “Buy” rating by Peel Hunt given on Friday, April 15. As per Wednesday, February 24, the company rating was maintained by FinnCap. Peel Hunt maintained the stock with “Buy” rating in Wednesday, July 20 report. The firm has “Buy” rating by FinnCap given on Monday, January 11. On Monday, November 30 the stock rating was maintained by FinnCap with “Buy”. Peel Hunt maintained the stock with “Buy” rating in Thursday, April 7 report.
ACAL plc designs, manufactures and distributes electronic products and solutions. The company has a market cap of 135.85 million GBP. The Firm operates through two divisions: Custom Distribution and Design & Manufacturing. It has a 19.62 P/E ratio. The Custom Distribution segment provides customized electronic, photonic and medical products to the industrial, medical and healthcare markets, both from a range of international suppliers and from the Company’s Design & Manufacturing division.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.